FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation

FDA Grants vTv’s Type 1 Diabetes Drug Breakthrough Therapy Designation

Source: 
BioSpace
snippet: 

The U.S. Food and Drug Administration (FDA) granted vTv Therapeutics’ TTP399 Breakthrough Therapy designation for type 1 diabetes. This designation provides companies more support and the possibility of shorter development and review timelines.